1. State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University & School of Life Sciences, Nanjing University, Nanjing 210093, China 2. Institute of Drug R&D, Nanjing University, Nanjing 210093, China 3. Jiangsu Provincial Key Laboratory for Nano Technology, Nanjing University, Nanjing 210093, China
Zhou Z, Zhang B, Wang H, Yuan A, Hu Y, Wu J. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum. Theranostics 2020; 10(7):2943. doi:10.7150/thno.42420. https://www.thno.org/v10p2943.htm
In our paper[1] and the supplementary materials, Figure 4F and Supplementary Figure 3A should be corrected as the following Figure A1 and Figure A2.
Figure A1
(Figure 4F). Representative western blot image to analyze HIF-1α expression in tumors from Vehicle and PFC@HSAs treated mice.
Figure A2
(Supplementary Figure 3A). Representative image of blood retraction after different PFC@HSAs treatments.
References
1.
Zhou Z, Zhang B, Wang H, Yuan A, Hu Y, Wu J. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics. 2018;8(18):4898-4911 doi:10.7150/thno.27598
Zhou, Z., Zhang, B., Wang, H., Yuan, A., Hu, Y., Wu, J. (2020). Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum. Theranostics, 10(7), 2943. https://doi.org/10.7150/thno.42420.
ACS
Zhou, Z.; Zhang, B.; Wang, H.; Yuan, A.; Hu, Y.; Wu, J. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum. Theranostics 2020, 10 (7), 2943. DOI: 10.7150/thno.42420.
NLM
Zhou Z, Zhang B, Wang H, Yuan A, Hu Y, Wu J. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum. Theranostics 2020; 10(7):2943. doi:10.7150/thno.42420. https://www.thno.org/v10p2943.htm
CSE
Zhou Z, Zhang B, Wang H, Yuan A, Hu Y, Wu J. 2020. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum. Theranostics. 10(7):2943.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.